SJS Investment Consulting’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562 | Sell |
13
-9
| -41% | -$389 | ﹤0.01% | 1075 |
|
|
2025
Q1 | $761 | Buy |
22
+15
| +214% | +$519 | ﹤0.01% | 1096 |
|
|
2024
Q4 | $193 | Sell |
7
-18
| -72% | -$496 | ﹤0.01% | 1463 |
|
|
2024
Q3 | $637 | Buy |
25
+2
| +9% | +$51 | ﹤0.01% | 1242 |
|
|
2024
Q2 | $583 | Buy |
23
+4
| +21% | +$101 | ﹤0.01% | 1236 |
|
|
2024
Q1 | $588 | Buy |
19
+2
| +12% | +$62 | ﹤0.01% | 1232 |
|
|
2023
Q4 | $687 | Buy |
17
+3
| +21% | +$121 | ﹤0.01% | 1115 |
|
|
2023
Q3 | $370 | Buy |
14
+5
| +56% | +$132 | ﹤0.01% | 1314 |
|
|
2023
Q2 | $155 | Buy |
9
+4
| +80% | +$69 | ﹤0.01% | 1453 |
|
|
2023
Q1 | $83 | Buy |
5
+3
| +150% | +$50 | ﹤0.01% | 1478 |
|
|
2022
Q4 | $15 | Hold |
2
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1056 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 732 |
|